Tadek R Hendriksz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tadek R Hendriksz

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Kidney Journal|March 18, 2016

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapyFloor E van der Bilt, Tadek R Hendriksz, Wilbert A G van der Meijden, et al.

Acta Oncologica (Stockholm, Sweden)|March 29, 2019

Sirolimus monotherapy for Erdheim-Chester diseaseEric F H van Bommel, Mark A van der Zijden, Peter J H Smak Gregoor, et al.

Blood|April 17, 2020

Long-term follow-up of mTOR inhibition for Erdheim-Chester diseaseFrancesco Pegoraro, Valerio Maniscalco, Francesco Peyronel, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Kidney Journal|March 18, 2016

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapyFloor E van der Bilt, Tadek R Hendriksz, Wilbert A G van der Meijden, et al.

Acta Oncologica (Stockholm, Sweden)|March 29, 2019

Sirolimus monotherapy for Erdheim-Chester diseaseEric F H van Bommel, Mark A van der Zijden, Peter J H Smak Gregoor, et al.

Blood|April 17, 2020

Long-term follow-up of mTOR inhibition for Erdheim-Chester diseaseFrancesco Pegoraro, Valerio Maniscalco, Francesco Peyronel, et al.

Pageof 2